Integrating Risk Management into the Pharmaceutical Quality System

  • A white background with a few lines on it

    Slide title

    "This course was very engaging and most importantly, the instructor was very knowledgeable. I was particularly grateful for the depth of discussion regarding medical devices vs. Pharma. So many courses I've taken have been totally Pharma focused."


    Kerry F., Medical Affairs Manager, Getinge

  • A white background with a few lines on it

    Slide title

    "The course was able to present real world examples that a QA/RA professional can relate to. The instructor led at a great pace and to every question provided a complete answer. I felt understood and really learned when I had an inquiry."


    Craig D., QA/RA Scientist, Promega

  • A white background with a few lines on it

    Slide title

    "I was very satisfied with this course. It’s what I expect from CfPIE. The interaction with the course instructor was very useful and I enjoyed the exercises and the workshop."


    Amir S., Design Quality Engineer, Zimmer Biomet

  • A white background with a few lines on it

    "The material was thorough and comprehensive. The Course Director is clearly an expert on risk management and the right person to teach the course. He is articulate, patient, and can cater the material to an audience in many different groups and industries. In addition, he has created several useful workshops that forced the class to apply the risk management principles he was teaching."


    Jonathan K., Quality Systems Specialist, Boehringer Ingelheim Chemicals

A man in a suit and tie with a plus sign on his chest.

Course Director

A dollar sign in a circle on a white background.

Course Fee

$1650.00 Regular Registration

$1450.00 Early Bird Pricing (Register 30 Days in Advance)

A black and white icon of a calendar on a white background.

Course Description

More than simply a regulatory checkbox, effective risk integration is the backbone of modern pharmaceutical risk-based decision-making. It transforms passive quality monitoring into an active defense strategy for patient safety and product integrity.



This 10-hour course equips you to integrate risk management principles into your quality system, ensuring compliance and promoting continuous improvement throughout the product life cycle.

What This Course Covers

Our course on integrating risk management into the pharmaceutical quality system covers:

Regulatory Requirements

Our curriculum is built around the latest quality risk management guidelines, such as the International Council for Harmonisation (ICH) Q9 (R1), and ensures your team understands the scientific rationale behind them.

We explore how to move beyond reactive compliance to proactive quality assurance, applying pharmaceutical risk evaluation principles that withstand scrutiny from the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA) and other global health authorities. You will learn to interpret regulatory expectations as frameworks for operational excellence.

Practical Application Across the Life Cycle

In this course, you will learn to apply risk-based thinking throughout every phase of drug and biologics development and manufacturing. You'll also gain a solid understanding of regulatory requirements, global standards and best practices and explore ways to enhance product and process comprehension through case studies and group discussions.

Specifically, we will cover:


  • Life cycle integration: We explore strategies for integrating risk management into the pharmaceutical quality system from initial research and development (R&D) through to commercial manufacturing and discontinuation. This approach ensures risk considerations are embedded at every stage rather than treated as separate compliance activities.
  • Risk assessment tools: This course covers methodologies for product life cycle risk assessment training, including hands-on training with failure mode and effects analysis (FMEA), hazard analysis and critical control point (HACCP) and preliminary hazard analysis (PHA). Participants will practice applying these tools to real-world scenarios, building confidence in selecting and implementing the most appropriate methodology for each situation.
  • Decision frameworks: You will learn how to build a structured approach for risk-based decision-making that justifies quality decisions to regulators. These frameworks provide clear documentation trails that demonstrate the scientific rationale behind quality choices, making regulatory interactions more straightforward and defensible.
  • Quality system synergy: Techniques for seamless risk management quality system integration ensure your quality management system (QMS) isn't siloed from your risk activities. This integration creates a unified approach where risk considerations naturally inform all quality processes and decision-making workflows.
  • Subjectivity reduction: This study covers methods to minimize bias in risk scoring, a key focus of the recent ICH Q9 revision. These techniques help teams achieve more consistent and objective risk evaluations, improving the reliability and regulatory acceptability of risk assessments across different evaluators and time periods.


The Business Case for Robust Risk Management

The industry is shifting. Regulators no longer accept one-size-fits-all quality systems. They expect a dynamic, risk-aware culture in which potential hazards are identified, analyzed and mitigated before they affect the patient. Beyond compliance, this approach drives business value. 

By reducing batch failures, minimizing deviations, and focusing resources on high-risk areas, companies can achieve significant cost savings and faster time-to-market. This course provides the blueprint for that cultural and operational shift, helping you avoid costly risk assessment pitfalls.

Professionals from industry-leading organizations, including Bayer, Merck, GSK, Boehringer Ingelheim, Johnson & Johnson, Alkermes, Otsuka, Promega, Getinge and W. L. Gore, have trusted this training to strengthen their risk management capabilities.


Who Should Attend Risk Management Quality System Integration Training?

Training on integrating risk management into the pharmaceutical quality system is a necessity for anyone overseeing or contributing to quality compliance in drug and biologic production.


Professional Roles

This course is ideal for:

  • Quality and production managers
  • Product development scientists and engineers
  • Regulatory professionals
  • Quality assurance specialists
  • Clinical research professionals
  • R&D staff
  • Management


Applicable Industries

This training is essential for professionals working in:

  • Pharmaceutical manufacturing companies
  • Biotechnology and biopharmaceutical organizations
  • Contract research organizations (CROs)
  • Contract development and manufacturing organizations (CDMOs)
  • Generic drug manufacturers
  • Medical device companies with pharmaceutical components
  • Regulatory consulting firms
  • Active pharmaceutical ingredient (API) producers


Register for Live Stream Request On-Site Details

Additional Course Information

  • Learning Objectives

    Upon completion of this course, attendees will understand how to effectively meet and integrate the requirements of quality systems management and risk management for drugs and biologics.


    Course Objectives Include:

    • Understand the principals of Risk Management, the terms and their relationships
    • Know the key Risk Management and Quality System regulations, requirements, standards, and guidance
    • Develop a working knowledge and application of tools used in Risk Management
    • Develop an understanding of how to integrate RM principals into a pharma/biologics QS
    • Understand and appreciate Product Life Cycle considerations and the significance of different types of risk evaluation in product development, process development, commercial tech transfer and ongoing GMP operations. 

  • Agenda

    DAY ONE


    Introduction and Overview

    • Risk: Patient - Product -  Process
    • Legacy vs. Life Cycle Compliance Approach
    1. Process analytical technology (PAT), QbD and ICH Q8 and Q10
    • Product Life Cycle Quality and Risk Management

    Regulatory Perspectives and Requirements

    • Understanding the difference between: laws, regulations, guidances, and standards
    • Quality System and Risk Management requirements and guidance
    1. US, 
    2. EU, 
    3. ICH/Harmonized 
    • Comparisons between the EU, U.S., and other countries

    Key Elements of Quality Risk Management

    • Organized Approach/Top level integration with the QMS
    • Risk Assessment:
    1. Risk Identification-hazards and harm matrix
    2. Risk analysis and evaluation: Introduction to key risk tools
    • Risk Control and Reduction: Reliability and Detectability
    • Risk Acceptance: 
    1. Severity/Likelihood Matrix-Considerations for determining Acceptable Risk 
    2. The importance of the Risk/Benefit analysis 

    Understanding Key Risk Analysis Tools

    • Process Mapping 
    • Hazard Analysis and Critical Control Points (HACCP) 
    • Hazard Operability Analysis (HAZOP) 
    • Cause and Effect Analysis 
    • Fault Tree Analysis (FTA) 
    • Failure Mode Effects Analysis (FMEA)

     

    DAY TWO


    Group Discussion

    • We will work together to evaluate and find possible /strategies to risk scenario brought forward by class participants.

    Risk Management Tools and Application to Product Development and Product Risk

    • Patient/Consumer risk and the Quality Target Product Profile
    • QbD - Risk Control -  Product Development
    • Product Realization and Specification of Critical Quality Attributes

    RM Tools and Applications in Process Development and Validation

    • Product/Process Development Transition
    • Process Understanding and Design Space
    • Scale Up -  Process Validation 

    RM for Maintaining and Improving cGMP Operations

    • Continuous Process Verification
    • CAPA
    • Tech Transfer
    • Change Control 

    Next level Risk Management Topics and Issues

    • Organizing a process and program for RM Integration
    • Preconception, misinterpretation: Their potential impact on Calculating Risk
    • Establishing Risk Responsibility-The importance of risk control effort being proportional to the magnitude of risk
    • Recap/Case Discussion

  • Testimonials

    "I found the course to be the right balance of informative and enjoyable. The interactive nature made the course interesting."

    Teri R., R&D Supervisor, Hitachi/MSSI


    "The course was exceptional! I enjoyed the interactive style of the Course Director."

    Krishna S., CEO, MSSI


    "It was a well-run course. I enjoyed all of the additional material provided on the flash drive."

    Erin J., Quality Systems Specialist, Sterilmed / J&J


    "Among the best courses I’ve taken outside of school. The course director was very knowledgeable and engaging."

    Patrick E., QC Analyst, Recro Pharma Gainesville


    "This course was very engaging and most importantly, the instructor was very knowledgeable. I was particularly grateful for the depth of discussion regarding medical devices vs. Pharma. So many courses I've taken have been totally Pharma focused."

    Kerry F., Medical Affairs Manager, Getinge


    "The course was able to present real world examples that a QA/RA professional can relate to. The instructor led at a great pace and to every question provided a complete answer. I felt understood and really learned when I had an inquiry."

    Craig D., QA/RA Scientist, Promega


    "I was very satisfied with this course. It’s what I expect from CfPIE. The interaction with the course instructor was very useful and I enjoyed the exercises and the workshop."

    Amir S., Design Quality Engineer, Zimmer Biomet


    "The presenter was extremely knowledgeable the examples provided were very beneficial."

    Gary S., Manager, Quality and Compliance, Morphotek


    "The course was a very good introduction to the concept of integrating Risk Management into the existing Quality management System. It was well presented and well explained."

    Ladi O., Device Safety Leader, Bayer


    "Great course, great spokesperson! Highly recommend! I for one especially appreciated the following, Real-life examples from all walks of business, Providing the standard, laws and guidance from a global perspective was very refreshing and enlightening and the Workshop was great as well."

    Goldi, Director, Pharm. Tech., Otsuka


    "The material was thorough and comprehensive. The Course Director is clearly an expert on risk management and the right person to teach the course. He is articulate, patient, and can cater the material to an audience in many different groups and industries. In addition, he has created several useful workshops that forced the class to apply the risk management principles he was teaching."

    Jonathan K., Quality Systems Specialist, Boehringer Ingelheim Chemicals


    "All course materials were helpful, especially the worksheets. I will be able to bring them back to my company and start using them to improve our processes. Instructor gave good insight into the FDA perspective and what an investigator would be looking for in a risk management plan."

    Leah S. Proc. Development Engineer, Alkermes


    "Excellent course, well delivered and useful notes I can refer to later. Good group exercises."

    Michael K., Department Manager, PM Group


    "This class will enable me to network and gain a better understanding of risks. Great job!"

    Kim B., Manager of GMP Quality, Merck


    "The Course Director was excellent in explaining material. When I came in, I didn't know much about the topic and when I left on the last day I felt like I could share ideas with others."

    Melissa R., Scientist, Business Operations, Glaxo (GSK)


    "The exercises give 'practical application' to the information given in the lecture."

    Christy, S., Quality Assurance, W.L. Gore & Associates


    "This course provided excellent tools that we will be able to implement immediately."

    Scott W., QA Manager Johnson & Johnson


    "The complicated topics were made simple and understandable for new QA staff."

    Raymond N., Sr. Medical Advisor & Safety Officer, Baxter

Registrant Information:

Each person attending a course will be asked to set up an Attendee Profile Account during the registration process. Creating an Account helps you view your order history and manage your training programs. If you are registering for others, please set up an Account in the Attendee’s name. If you are registering more than one person, you’ll need to set up a separate account for each Attendee.